PHARMA MAR, S.A. (PMRA.F)

81.89EUR -2.83% (-2.38)

Over 6M: +10.1%

2026-08-25

80 100

Mar Apr May Jun Jul Aug

Figures as at 2024-12-31, reported in EUR. The newest fact in the filings is dated 2025-01-01, 602 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.0

SBC / sales 0.0%

Oper. margin 3.7%

Adj. EBITDA margin 3.7%

ROIC 2.8%

OE margin -5.1%

Resilience

Can the balance sheet absorb a bad year?

6.7

Current ratio 3.0×

ND/EBITDA —

Interest cover 0.76×

Growth

Is the business getting bigger, and is it getting more profitable?

2.5

Sales/sh Y/Y +10.6%

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.

The ratios

The figures themselves rather than their scores — what somebody looking up PMRA.F on one particular measure came for.

Ratio	Value
cash operating margin	3.7
current ratio	3.03
current ratio reported	3.03
fcf margin	-5.14
interest cover	0.76
operating margin	3.7
owner earnings margin	-5.14
revenue growth	10.56
revenue growth per share	10.56
roic	2.76
rule of 40	14.26
sbc pct revenue	0.0

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

Figure	Value	XBRL tag	As at
capex	15,015,000	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	2024-12-31
cash	63,239,000	`CashAndCashEquivalents`	2025-01-01
current assets	250,248,000	`CurrentAssets`	2025-01-01
current liabilities	82,694,000	`CurrentLiabilities`	2025-01-01
equity	208,359,000	`EquityAttributableToOwnersOfParent`	2025-01-01
interest expense	8,528,000	`FinanceCosts`	2024-12-31
ocf	6,027,000	`CashFlowsFromUsedInOperatingActivities`	2024-12-31
revenue	174,855,000	`RevenueFromContractsWithCustomers`	2024-12-31
sbc	0	`AdjustmentsForSharebasedPayments`	2024-12-31

What to be careful about

newest fact in the filing is 2025-01-01 (1y old); this company's data is not usable and the scores below should be ignored
revenue is annual, not TTM
operating income is annual, not TTM
revenue period ends 2024-12-31 (603 days ago) - the tag chain found nothing recent, so treat this row as unscored
no market cap; set `market_cap` in overrides.yaml
no usable diluted share count, so growth is measured on total revenue rather than per share; a company issuing shares to fund that growth reads better than it is

See it scored yourself

The dashboard puts PMRA.F beside other companies and lets you change what counts: the weight of each dimension, the value that earns a ten, and which of the 61 measures are included at all.